Literature DB >> 30310485

Mitral Regurgitation - A Multidisciplinary Challenge.

Eduardo Alegria-Barrero1, Olaf W Franzen2.   

Abstract

Mitral regurgitation is an increasing valvular disease that represents a difficult management challenge. Surgical treatment for degenerative mitral regurgitation is the standard of care treatment. Percutaneous therapies have emerged rapidly over the past years as an option for treatment of mitral regurgitation for selected, predominantly high-risk patients. Catheter-based devices mimic these surgical approaches with less procedural risk. Mitraclip® implantation mimics the surgical edge-to-edge leaflet repair technique, reducing the regurgitant area. We review the increasing evidence with the Mitraclip device reported to date.

Entities:  

Keywords:  Mitral valve; degenerative mitral regurgitation; functional mitral regurgitation; mitraclip; mitral regurgitation; mitral valve surgery

Year:  2014        PMID: 30310485      PMCID: PMC6159436          DOI: 10.15420/ecr.2014.9.1.49

Source DB:  PubMed          Journal:  Eur Cardiol        ISSN: 1758-3756


  42 in total

1.  Dissociation between anatomical and functional results after MitraClip implantation.

Authors:  Pak Hei Chan; Carlo Di Mario; Olaf Franzen
Journal:  Int J Cardiol       Date:  2011-11-09       Impact factor: 4.164

Review 2.  [Surgical echocardiography of the mitral valve].

Authors:  Javier G Castillo; Jorge Solís; Angel González-Pinto; David H Adams
Journal:  Rev Esp Cardiol       Date:  2011-10-26       Impact factor: 4.753

3.  Acute outcomes of MitraClip therapy for mitral regurgitation in high-surgical-risk patients: emphasis on adverse valve morphology and severe left ventricular dysfunction.

Authors:  Olaf Franzen; Stephan Baldus; Volker Rudolph; Sven Meyer; Malgorzata Knap; Dietmar Koschyk; Hendrik Treede; Achim Barmeyer; Joachim Schofer; Angelika Costard-Jäckle; Michael Schlüter; Hermann Reichenspurner; Thomas Meinertz
Journal:  Eur Heart J       Date:  2010-03-10       Impact factor: 29.983

4.  Very long-term results (more than 20 years) of valve repair with carpentier's techniques in nonrheumatic mitral valve insufficiency.

Authors:  E Braunberger; A Deloche; A Berrebi; F Abdallah; J A Celestin; P Meimoun; G Chatellier; S Chauvaud; J N Fabiani; A Carpentier
Journal:  Circulation       Date:  2001-09-18       Impact factor: 29.690

5.  Percutaneous mitral valve interventions in the real world: early and 1-year results from the ACCESS-EU, a prospective, multicenter, nonrandomized post-approval study of the MitraClip therapy in Europe.

Authors:  Francesco Maisano; Olaf Franzen; Stephan Baldus; Ulrich Schäfer; Jörg Hausleiter; Christian Butter; Gian Paolo Ussia; Horst Sievert; Gert Richardt; Julian D Widder; Tiziano Moccetti; Wolfgang Schillinger
Journal:  J Am Coll Cardiol       Date:  2013-06-07       Impact factor: 24.094

6.  Real-world experience of MitraClip for treatment of severe mitral regurgitation.

Authors:  Pak Hei Chan; Hoi Lam She; Eduardo Alegria-Barrero; Neil Moat; Carlo Di Mario; Olaf Franzen
Journal:  Circ J       Date:  2012-07-03       Impact factor: 2.993

7.  Percutaneous approaches to mitral regurgitation.

Authors:  Faisal Alqoofi; Ted Feldman
Journal:  Curr Treat Options Cardiovasc Med       Date:  2009-12

8.  Early outcome of mitral valve reconstruction in patients with end-stage cardiomyopathy.

Authors:  S F Bolling; G M Deeb; L A Brunsting; D S Bach
Journal:  J Thorac Cardiovasc Surg       Date:  1995-04       Impact factor: 5.209

9.  Advanced heart failure treated with continuous-flow left ventricular assist device.

Authors:  Mark S Slaughter; Joseph G Rogers; Carmelo A Milano; Stuart D Russell; John V Conte; David Feldman; Benjamin Sun; Antone J Tatooles; Reynolds M Delgado; James W Long; Thomas C Wozniak; Waqas Ghumman; David J Farrar; O Howard Frazier
Journal:  N Engl J Med       Date:  2009-11-17       Impact factor: 91.245

10.  Recurrent mitral regurgitation and risk factors for early and late mortality after mitral valve repair for functional ischemic mitral regurgitation.

Authors:  Traves D Crabtree; Marci S Bailey; Marc R Moon; Nabil Munfakh; Michael K Pasque; Jennifer S Lawton; Nader Moazami; Kristen A Aubuchon; Ashraf S Al-Dadah; Ralph J Damiano
Journal:  Ann Thorac Surg       Date:  2008-05       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.